BRC Consultant in Paediatrics and Vaccinology.
- Honorary Senior Clinical Lecturer
Vaccines and vaccine preventable disease in childhood
I am a BRC funded consultant in paediatrics and vaccinology. I undertook clinical training in paediatrics in Oxford, Reading, Melbourne, Vancouver and Yorkshire. I completed a PhD in 2008 within the Oxford Vaccine Group and began my current post in 2009. I divide my time between working in general paediatrics and paediatric infectious disease/immunology at the Children’s Hospital in Oxford and vaccine related research within the Oxford Vaccine Group.
Impact of Vaccination on Haemophilus influenzae Type b Carriage in Healthy Children Less Than 5 Years of Age in an Urban Population in Nepal.
Shrestha S. et al, (2021), J Infect Dis, 224, S267 - S274
Fatal tuberculous meningitis in an infant presenting with seizures in the UK.
Khambati N. et al, (2021), BMJ Case Rep, 14
Persistence of Immunity Following 2-Dose Priming with a 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks or 6 and 14 Weeks of Age in Nepalese Toddlers.
Gurung M. et al, (2021), Pediatr Infect Dis J
Corrigendum to 'Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom'.
Versteegen P. et al, (2021), EBioMedicine, 68
A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process.
Harwood R. et al, (2021), Lancet Child Adolesc Health, 5, 133 - 141